{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:08:50Z","timestamp":1761293330990},"reference-count":15,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11,1]]},"DOI":"10.1210\/en.2015-1802","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T21:31:22Z","timestamp":1445031082000},"page":"3880-3881","source":"Crossref","is-referenced-by-count":1,"title":["Strategic Chemotherapy for Pheochromocytoma?"],"prefix":"10.1210","volume":"156","author":[{"given":"Hans K.","family":"Ghayee","sequence":"first","affiliation":[{"name":"University of Florida College of Medicine, Gainesville, Florida 32603"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"key":"2020071612333937400_B1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP14481.RA","article-title":"Pheochromocytoma and paraganglioma","volume":"21","author":"Pacak","year":"2015","journal-title":"Endocr Pract"},{"key":"2020071612333937400_B2","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612333937400_B3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jhh.2012.20","article-title":"An update on the genetics of pheochromocytoma","volume":"27","author":"Karasek","year":"2013","journal-title":"J Hum Hypertens"},{"key":"2020071612333937400_B4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2020071612333937400_B5","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2020071612333937400_B6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cen.12341","article-title":"(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis","volume":"80","author":"van Hulsteijn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071612333937400_B7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1210\/jc.2008-1836","article-title":"Rationale and evidence for sunitinib in the treatment of malignant paraganglioma\/pheochromocytoma","volume":"94","author":"Joshua","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612333937400_B8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1055\/s-0029-1220687","article-title":"Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001)","volume":"41","author":"Druce","year":"2009","journal-title":"Horm Metab Res"},{"key":"2020071612333937400_B9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/eci.12127","article-title":"Phospho-mTOR is not upregulated in metastatic SDHB paragangliomas","volume":"43","author":"Ghayee","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"2020071612333937400_B10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/en.2012-1854","article-title":"Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice","volume":"154","author":"Giubellino","year":"2013","journal-title":"Endocrinology"},{"key":"2020071612333937400_B11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","article-title":"Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine","volume":"109","author":"Averbuch","year":"1988","journal-title":"Ann Intern Med"},{"key":"2020071612333937400_B12","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/cncr.26577","article-title":"Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience","volume":"118","author":"Ayala-Ramirez","year":"2012","journal-title":"Cancer"},{"key":"2020071612333937400_B13","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1210\/en.2015-1476","article-title":"Inhibitory effect of the non-camptothecin topoisomerase I inhibitor LMP-400 on female mice models and human pheochromocytoma cells","volume":"156","author":"Schovanek","year":"2015","journal-title":"Endocrinology"},{"key":"2020071612333937400_B14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"2020071612333937400_B15","doi-asserted-by":"crossref","first-page":"e65624","DOI":"10.1371\/journal.pone.0065624","article-title":"Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor","volume":"8","author":"Ghayee","year":"2013","journal-title":"PLoS One"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/11\/3880\/8985889\/endo3880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/11\/3880\/8985889\/endo3880.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:39:56Z","timestamp":1594931996000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/156\/11\/3880\/2422611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,1]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2015-1802","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,1]]}}}